vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and Tecnoglass Inc. (TGLS). Click either name above to swap in a different company.
Tecnoglass Inc. is the larger business by last-quarter revenue ($245.3M vs $205.4M, roughly 1.2× COLLEGIUM PHARMACEUTICAL, INC). Tecnoglass Inc. runs the higher net margin — 10.6% vs 8.3%, a 2.4% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs 2.4%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $11.4M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 12.8%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
Tecnoglass Inc. is a leading manufacturer of high-performance architectural glass, aluminum windows, doors, and associated building components. It primarily caters to residential and commercial construction sectors across North America and Latin America, offering custom, energy-efficient solutions for new construction and renovation projects.
COLL vs TGLS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $245.3M |
| Net Profit | $17.0M | $26.1M |
| Gross Margin | 62.5% | 40.0% |
| Operating Margin | 29.6% | 18.3% |
| Net Margin | 8.3% | 10.6% |
| Revenue YoY | 12.9% | 2.4% |
| Net Profit YoY | 35.3% | -44.5% |
| EPS (diluted) | $0.48 | $0.57 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $205.4M | $245.3M | ||
| Q3 25 | $209.4M | $260.5M | ||
| Q2 25 | $188.0M | $255.5M | ||
| Q1 25 | $177.8M | $222.3M | ||
| Q4 24 | $181.9M | $239.6M | ||
| Q3 24 | $159.3M | $238.3M | ||
| Q2 24 | $145.3M | $219.7M | ||
| Q1 24 | $144.9M | $192.6M |
| Q4 25 | $17.0M | $26.1M | ||
| Q3 25 | $31.5M | $47.2M | ||
| Q2 25 | $12.0M | $44.1M | ||
| Q1 25 | $2.4M | $42.2M | ||
| Q4 24 | $12.5M | $47.0M | ||
| Q3 24 | $9.3M | $49.5M | ||
| Q2 24 | $19.6M | $35.0M | ||
| Q1 24 | $27.7M | $29.7M |
| Q4 25 | 62.5% | 40.0% | ||
| Q3 25 | 61.7% | 42.7% | ||
| Q2 25 | 57.7% | 44.7% | ||
| Q1 25 | 54.8% | 43.9% | ||
| Q4 24 | 54.0% | 44.5% | ||
| Q3 24 | 60.8% | 45.8% | ||
| Q2 24 | 62.5% | 40.8% | ||
| Q1 24 | 63.1% | 38.8% |
| Q4 25 | 29.6% | 18.3% | ||
| Q3 25 | 29.7% | 25.1% | ||
| Q2 25 | 18.7% | 24.0% | ||
| Q1 25 | 12.2% | 26.7% | ||
| Q4 24 | 20.9% | 28.0% | ||
| Q3 24 | 21.9% | 28.4% | ||
| Q2 24 | 32.7% | 23.3% | ||
| Q1 24 | 34.1% | 21.3% |
| Q4 25 | 8.3% | 10.6% | ||
| Q3 25 | 15.0% | 18.1% | ||
| Q2 25 | 6.4% | 17.3% | ||
| Q1 25 | 1.4% | 19.0% | ||
| Q4 24 | 6.9% | 19.6% | ||
| Q3 24 | 5.9% | 20.8% | ||
| Q2 24 | 13.5% | 15.9% | ||
| Q1 24 | 19.1% | 15.4% |
| Q4 25 | $0.48 | $0.57 | ||
| Q3 25 | $0.84 | $1.01 | ||
| Q2 25 | $0.34 | $0.94 | ||
| Q1 25 | $0.07 | $0.90 | ||
| Q4 24 | $0.36 | $1.00 | ||
| Q3 24 | $0.27 | $1.05 | ||
| Q2 24 | $0.52 | $0.75 | ||
| Q1 24 | $0.71 | $0.63 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | $104.1M |
| Total DebtLower is stronger | — | $174.4M |
| Stockholders' EquityBook value | $301.7M | $713.1M |
| Total Assets | $1.7B | $1.3B |
| Debt / EquityLower = less leverage | — | 0.24× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $386.7M | $104.1M | ||
| Q3 25 | $285.9M | $127.1M | ||
| Q2 25 | $222.2M | $140.9M | ||
| Q1 25 | $197.8M | $160.2M | ||
| Q4 24 | $162.8M | $137.5M | ||
| Q3 24 | $120.0M | $124.8M | ||
| Q2 24 | $271.6M | $129.5M | ||
| Q1 24 | $318.0M | $138.8M |
| Q4 25 | — | $174.4M | ||
| Q3 25 | — | $114.7M | ||
| Q2 25 | — | $110.6M | ||
| Q1 25 | — | $110.6M | ||
| Q4 24 | — | $111.1M | ||
| Q3 24 | — | $126.8M | ||
| Q2 24 | — | $144.7M | ||
| Q1 24 | — | $160.9M |
| Q4 25 | $301.7M | $713.1M | ||
| Q3 25 | $274.8M | $764.0M | ||
| Q2 25 | $232.2M | $736.0M | ||
| Q1 25 | $234.4M | $685.1M | ||
| Q4 24 | $228.8M | $631.2M | ||
| Q3 24 | $234.3M | $613.3M | ||
| Q2 24 | $216.6M | $574.8M | ||
| Q1 24 | $222.2M | $573.6M |
| Q4 25 | $1.7B | $1.3B | ||
| Q3 25 | $1.6B | $1.2B | ||
| Q2 25 | $1.6B | $1.2B | ||
| Q1 25 | $1.6B | $1.1B | ||
| Q4 24 | $1.7B | $1.0B | ||
| Q3 24 | $1.6B | $996.3M | ||
| Q2 24 | $1.1B | $942.5M | ||
| Q1 24 | $1.1B | $981.6M |
| Q4 25 | — | 0.24× | ||
| Q3 25 | — | 0.15× | ||
| Q2 25 | — | 0.15× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.18× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.25× | ||
| Q1 24 | — | 0.28× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | $31.0M |
| Free Cash FlowOCF − Capex | $122.4M | $11.4M |
| FCF MarginFCF / Revenue | 59.6% | 4.7% |
| Capex IntensityCapex / Revenue | 0.3% | 8.0% |
| Cash ConversionOCF / Net Profit | 7.25× | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | $34.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $123.0M | $31.0M | ||
| Q3 25 | $78.4M | $40.0M | ||
| Q2 25 | $72.4M | $17.9M | ||
| Q1 25 | $55.4M | $46.9M | ||
| Q4 24 | $84.6M | $61.1M | ||
| Q3 24 | $-9.0M | $41.5M | ||
| Q2 24 | $67.4M | $34.5M | ||
| Q1 24 | $61.9M | $33.4M |
| Q4 25 | $122.4M | $11.4M | ||
| Q3 25 | $78.3M | $21.2M | ||
| Q2 25 | $72.4M | $-14.7M | ||
| Q1 25 | $54.6M | $16.5M | ||
| Q4 24 | $84.1M | $35.4M | ||
| Q3 24 | $-9.2M | $17.8M | ||
| Q2 24 | $67.1M | $14.2M | ||
| Q1 24 | $61.4M | $23.6M |
| Q4 25 | 59.6% | 4.7% | ||
| Q3 25 | 37.4% | 8.2% | ||
| Q2 25 | 38.5% | -5.7% | ||
| Q1 25 | 30.7% | 7.4% | ||
| Q4 24 | 46.2% | 14.8% | ||
| Q3 24 | -5.8% | 7.5% | ||
| Q2 24 | 46.2% | 6.5% | ||
| Q1 24 | 42.3% | 12.2% |
| Q4 25 | 0.3% | 8.0% | ||
| Q3 25 | 0.1% | 7.2% | ||
| Q2 25 | 0.0% | 12.7% | ||
| Q1 25 | 0.4% | 13.7% | ||
| Q4 24 | 0.3% | 10.7% | ||
| Q3 24 | 0.2% | 9.9% | ||
| Q2 24 | 0.2% | 9.2% | ||
| Q1 24 | 0.4% | 5.1% |
| Q4 25 | 7.25× | 1.19× | ||
| Q3 25 | 2.49× | 0.85× | ||
| Q2 25 | 6.05× | 0.41× | ||
| Q1 25 | 22.92× | 1.11× | ||
| Q4 24 | 6.75× | 1.30× | ||
| Q3 24 | -0.96× | 0.84× | ||
| Q2 24 | 3.44× | 0.98× | ||
| Q1 24 | 2.23× | 1.13× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
COLL
Segment breakdown not available.
TGLS
| Product Sales | $164.2M | 67% |
| Fixed Price Contracts | $81.1M | 33% |
| Related Party | $692.0K | 0% |
